Suzuki, T., Maruyama, D., Machida, R., Kataoka, T., Fukushima, N., Takayama, N., . . . Nagai, H. (2023). Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105. Hematological oncology, 41(3), 590-593.
Chicago Style (17th ed.) CitationSuzuki, Tomotaka, et al. "Prognostic Impact of the UK Myeloma Research Alliance Risk Profile in Transplant‐ineligible Patients with Multiple Myeloma Who Received a Melphalan, Prednisolone, and Bortezomib Regimen: A Supplementary Analysis of JCOG1105." Hematological Oncology 41, no. 3 (2023): 590-593.
MLA (8th ed.) CitationSuzuki, Tomotaka, et al. "Prognostic Impact of the UK Myeloma Research Alliance Risk Profile in Transplant‐ineligible Patients with Multiple Myeloma Who Received a Melphalan, Prednisolone, and Bortezomib Regimen: A Supplementary Analysis of JCOG1105." Hematological Oncology, vol. 41, no. 3, 2023, pp. 590-593.
Visit our Citation Styles guide for help on properly citing sources.